← Back to Search

Social Engagement Service for Dementia

N/A

Waitlist Available

Led By Michael Skrajner, MA

Research Sponsored by Hopeful Aging

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up post-treatment--that is week 13 thru week 14

Awards & highlights

Study Summary

This trial is testing a new service that will allow people with disabilities to participate in group activities with their peers via videoconference. The trial will assess the feasibility and satisfaction of the service.

Who is the study for?

This trial is for individuals aged 65 or older with any type of dementia, who can speak and read English. It's also open to staff and family members over 18 who meet the same language criteria. Those with rapid cognitive or physical decline in the last six months cannot participate.Check my eligibility

What is being tested?

The study is testing 'SAFE at Home' (SaH), a service providing videoconference-based group activities for people with dementia (PWD). The SaH app will be evaluated on its usability, how engaging it is, and satisfaction levels from PWD and life enrichment staff.See study design

What are the potential side effects?

Since this intervention involves social engagement rather than medication, traditional side effects are not expected. However, participants may experience varying degrees of comfort with technology use or feelings of frustration if technical issues arise.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ post-treatment--that is week 13 thru week 14

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~post-treatment--that is week 13 thru week 14

This trial's timeline: 3 weeks for screening, Varies for treatment, and post-treatment--that is week 13 thru week 14 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Menorah Park Engagement Scale (MPES)

Secondary outcome measures

Dementia

Geriatric Depression Scale-Short Form (GDS-SF)

Neuropsychiatric Inventory-Nursing Home (NPI-NH)

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: TreatmentExperimental Treatment1 Intervention

SAFE at Home Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Hopeful AgingLead Sponsor

5 Previous Clinical Trials

629 Total Patients Enrolled

5 Trials studying Dementia

629 Patients Enrolled for Dementia

The Hearthstone Institute, LLCLead Sponsor

4 Previous Clinical Trials

509 Total Patients Enrolled

4 Trials studying Dementia

509 Patients Enrolled for Dementia

Michael Skrajner, MAPrincipal InvestigatorThe Hearthstone Institute

3 Previous Clinical Trials

313 Total Patients Enrolled

3 Trials studying Dementia

313 Patients Enrolled for Dementia

Media Library

SAFE at Home Clinical Trial Eligibility Overview. Trial Name: NCT05516147 — N/A

Dementia Research Study Groups: Treatment

Dementia Clinical Trial 2023: SAFE at Home Highlights & Side Effects. Trial Name: NCT05516147 — N/A

SAFE at Home 2023 Treatment Timeline for Medical Study. Trial Name: NCT05516147 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment still open for volunteers in this trial?

"Contrary to the information displayed on clinicaltrials.gov, this medical trial is no longer actively seeking out patients for recruitment. It was first posted in January of 2023 and it has not been updated since August 2022. Fortunately, there are many other studies currently enrolling participants at this time with 767 trials open right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SAFE at Home: A Service to Provide Social Engagement to Community-Dwelling Persons With Dementia

2024. "SAFE at Home: A Service to Provide Social Engagement to Community-Dwelling Persons With Dementia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05516147.